Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
AFBI
|
Howard G Roberts
Director |
BUY
Open market or private purchase
|
Direct | 3,000 Added 23.44% |
$32,550
$10.85 p/Share
|
Jan 21
2021 |
|
AFBI
|
Robin S Reich
Director |
BUY
Open market or private purchase
|
Direct | 6,970 Added 46.95% |
$75,137
$10.78 p/Share
|
Jan 21
2021 |
|
NYC
|
Edward M Weil Jr.
Director |
BUY
Open market or private purchase
|
Direct | 150 Added 2.82% |
$1,462
$9.75 p/Share
|
Jan 21
2021 |
|
MRUS
|
Bvf Partners L P
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 844,680 Added 66.46% |
$20,905,830
$24.75 p/Share
|
Jan 21
2021 |
|
FAST
|
Michael J Ancius
Director |
BUY
Open market or private purchase
|
Indirect | 600 Added 16.32% |
$29,046
$48.41 p/Share
|
Jan 21
2021 |
|
THO
|
Peter Busch Orthwein |
BUY
Open market or private purchase
|
Indirect | 130,400 Added 50.0% |
-
|
Jan 21
2021 |
|
HSON
|
Jeffrey E. Eberwein
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 1,000 Added 0.95% |
$13,650
$13.65 p/Share
|
Jan 21
2021 |
|
TSRI
|
Bradley M Tirpak
Director |
BUY
Open market or private purchase
|
Direct | 5,758 Added 50.0% |
$35,700
$6.2 p/Share
|
Jan 21
2021 |
|
DFCO
|
Brian Bonar
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 8,500 Added 0.16% |
$2,295
$0.27 p/Share
|
Jan 21
2021 |
|
WMT
|
Marc E. Lore
Executive Vice President |
SELL
Open market or private sale
|
Direct | 35,000 Reduced 2.87% |
$5,080,250
$145.15 p/Share
|
Jan 21
2021 |
|
MA
|
Foundation Mastercard |
SELL
Open market or private sale
|
Direct | 57,198 Reduced 0.05% |
$19,113,856
$334.17 p/Share
|
Jan 21
2021 |
|
ETR
|
Andrew S Marsh
Chair and CEO |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 4.43% |
$377,280
$94.32 p/Share
|
Jan 21
2021 |
|
NET
|
Matthew Prince
CEO & Board Co-Chair |
SELL
Open market or private sale
|
Indirect | 52,385 Reduced 62.46% |
$4,376,243
$83.54 p/Share
|
Jan 21
2021 |
|
GH
|
Helmy Eltoukhy
Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 173,206 Reduced 5.85% |
$28,068,033
$162.05 p/Share
|
Jan 21
2021 |
|
EXTR
|
Edward Meyercord
PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 0.27% |
$12,000
$8.0 p/Share
|
Jan 21
2021 |
|
GNK
|
Ccp Ii Cayman Gp Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.68% |
$259,800
$8.66 p/Share
|
Jan 21
2021 |
|
GNK
|
Centerbridge Credit Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.68% |
$259,800
$8.66 p/Share
|
Jan 21
2021 |
|
RMNI
|
Kevin Maddock
EVP,ChiefRecurringRev.Officer |
SELL
Open market or private sale
|
Direct | 5,320 Reduced 11.37% |
$40,166
$7.55 p/Share
|
Jan 21
2021 |
|
SFIX
|
Katrina Lake
Director |
SELL
Open market or private sale
|
Indirect | 43,778 Reduced 68.36% |
$3,598,989
$82.21 p/Share
|
Jan 21
2021 |
|
GTHX
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 19.61% |
$206,400
$20.64 p/Share
|
Jan 21
2021 |
|
XGN
|
Hunt Holdings Limited Partnership
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 50,000 Reduced 3.67% |
$800,500
$16.01 p/Share
|
Jan 21
2021 |
|
APLT
|
Riccardo Perfetti
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 465 Reduced 100.0% |
$9,439
$20.3 p/Share
|
Jan 21
2021 |
|
OPXS
|
Ephraim G Fields
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 12,700 Reduced 1.11% |
$25,654
$2.02 p/Share
|
Jan 21
2021 |
|
MDLA
|
Borge Hald
Director |
SELL
Open market or private sale
|
Direct | 53,654 Reduced 2.48% |
$2,146,696
$40.01 p/Share
|
Jan 21
2021 |
|
MDLA
|
Leslie Stretch
President and CEO |
SELL
Open market or private sale
|
Direct | 59,788 Reduced 4.77% |
$2,392,716
$40.02 p/Share
|
Jan 21
2021 |
|
CDXS
|
Byron L Dorgan |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 13.31% |
$629,250
$25.17 p/Share
|
Jan 21
2021 |
|
ZUMZ
|
Thomas D Campion
Chairman of Board of Directors |
SELL
Open market or private sale
|
Direct | 60,935 Reduced 4.88% |
$2,630,564
$43.17 p/Share
|
Jan 21
2021 |
|
WM
|
Frank M Clark
Director |
SELL
Open market or private sale
|
Direct | 301 Reduced 0.9% |
$34,356
$114.14 p/Share
|
Jan 21
2021 |
|
ROK
|
Blake D. Moret
President and CEO |
SELL
Open market or private sale
|
Direct | 16,900 Reduced 25.69% |
$4,530,552
$268.08 p/Share
|
Jan 21
2021 |
|
RNG
|
Vaibhav Agarwal
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 384 Reduced 2.52% |
$146,243
$380.84 p/Share
|
Jan 21
2021 |
|
JWN
|
Christine Deputy
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 15,947 Reduced 21.83% |
$576,006
$36.12 p/Share
|
Jan 21
2021 |
|
AMK
|
Michael Kim
CEO and President |
SELL
Open market or private sale
|
Direct | 637 Reduced 0.22% |
$15,931
$25.01 p/Share
|
Jan 21
2021 |
|
AMK
|
Gary G. Zyla
EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,909 Reduced 1.14% |
$47,725
$25.0 p/Share
|
Jan 21
2021 |
|
BKE
|
Kelli D Molczyk
SVP Women's Merchandising |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 4.53% |
$66,060
$33.03 p/Share
|
Jan 21
2021 |
|
CDXS
|
Bernard J Kelley
Director |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 1.18% |
$62,450
$24.98 p/Share
|
Jan 21
2021 |
|
WLY
|
Matthew Leavy
EVP & GM, Academic |
SELL
Open market or private sale
|
Direct | 500 Reduced 48.73% |
$23,655
$47.31 p/Share
|
Jan 21
2021 |
|
LEGH
|
Curtis Drew Hodgson
Director |
SELL
Open market or private sale
|
Indirect | 2,885 Reduced 0.1% |
$44,458
$15.41 p/Share
|
Jan 21
2021 |
|
ATAO
|
Erop Capital LLC |
SELL
Open market or private sale
|
Direct | 890,718 Reduced 1.94% |
$213,772
$0.24 p/Share
|
Jan 21
2021 |
|
ADPT
|
Julie Rubinstein
President and COO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$1,003,200
$66.88 p/Share
|
Jan 21
2021 |
|
MRNA
|
Stephane Bancel
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.13% |
$1,252,800
$125.28 p/Share
|
Jan 21
2021 |
|
MOTS
|
Perceptive Advisors LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 674,352 Reduced 17.36% |
$1,132,911
$1.68 p/Share
|
Jan 21
2021 |
|
PCVX
|
Robert Lorne Hopfner
Director |
SELL
Open market or private sale
|
Indirect | 100 Reduced 0.01% |
$2,511
$25.11 p/Share
|
Jan 21
2021 |
|
DIS
|
Robert A Iger
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,300 Reduced 0.11% |
$227,500
$175.0 p/Share
|
Jan 21
2021 |
|
ZM
|
Eric S. Yuan
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 70,142 Reduced 100.0% |
$26,528,405
$378.21 p/Share
|
Jan 21
2021 |
|
HARP
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect | 26,066 Reduced 0.2% |
$595,087
$22.83 p/Share
|
Jan 21
2021 |
|
IBKR
|
Thomas Aj Frank
Executive Vice President |
SELL
Open market or private sale
|
Direct | 18,008 Reduced 1.41% |
$1,229,766
$68.29 p/Share
|
Jan 21
2021 |
|
IBKR
|
Paul Jonathan Brody
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 2,507 Reduced 0.98% |
$171,203
$68.29 p/Share
|
Jan 21
2021 |
|
CNXC
|
Richard Rosso
EVP, Global Sales & Acct. Mgmt |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 6.68% |
$179,250
$119.5 p/Share
|
Jan 21
2021 |
|
TNET
|
H Raymond Bingham
Director |
SELL
Open market or private sale
|
Indirect | 415 Reduced 0.19% |
$33,881
$81.64 p/Share
|
Jan 21
2021 |
|
MRCY
|
Mark Aslett
President and CEO |
SELL
Open market or private sale
|
Direct | 1,250 Reduced 0.49% |
$99,375
$79.5 p/Share
|
Jan 21
2021 |